시장보고서
상품코드
1735879

세계의 임상의사결정지원시스템(CDSS) 시장(2024-2030년)

Clinical Decision Support System Market, Global, 2024-2030

발행일: | 리서치사: Frost & Sullivan | 페이지 정보: 영문 54 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

AI 통합으로 임상 결과 개선 및 혁신적 성장 견인

효과적인 집단건강관리에 대한 관심이 높아짐에 따라 의료 기관은 차세대 임상 의사결정 지원 도구의 도입을 촉진하고 시장 성장을 주도하고 있습니다. 의료 시스템은 임상 품질과 효율성에 대한 심각한 도전에 직면하고 있으며, 임상의사결정지원시스템(CDSS)의 도입에 대한 관심이 높아지고 있습니다. 이러한 도구는 병원과 재택의료 환경 모두에서 조기 진단과 적시에 정확한 임상적 개입을 촉진합니다. 또한 환자의 합병증 예방에도 도움이 되어 입원이나 중환자실 입실과 같은 비용이 많이 드는 개입의 필요성을 줄일 수 있습니다. 생성형 AI와 대화형 AI를 포함한 인공지능(AI)과 머신러닝의 기술 발전은 CDSS 솔루션의 지속적인 혁신을 촉진하고 있습니다.

Frost & Sullivan의 보고서는 세계 CDSS 시장에 대한 개요를 제공하고, 의사결정 증거/프로토콜, 의사결정 워크플로우, 의사결정 분석, 의사결정 전달의 각 애플리케이션 부문에 대한 수익 예측을 포함한 상세한 분석을 제공합니다. 또한, 이 시장의 촉진요인과 억제요인을 검토하고, 이 분야의 변화로 인해 시장 기업 및 관계자들이 활용해야 할 기회를 식별합니다. 기준 연도는 2024년, 예측 기간은 2025년부터 2030년까지입니다.

수익 예측

기준 연도인 2024년 매출 추정치는 107억 5,280만 달러이며, 2024년부터 2030년까지 조사 기간 동안 7.6%의 CAGR을 기록할 것으로 예상됩니다.

주요 경쟁사

  • Optum
  • EBSCO
  • Elsevier
  • Hearst Health
  • Merative
  • Medicomp Systems
  • Wolters Kluwer
  • RethinkFirst
  • Glass Health
  • UNORK
  • Premier Inc.(STANTON HEALTH)
  • Getinge
  • Motive Medical Intelligence
  • athenahealth
  • EvidenceCare
  • HCA Healthcare
  • MEDITECH
  • eClinicalWorks
  • Wolters Kluwer
  • RIMIDI
  • Inovalon
  • Vizio
  • Flatiron Health(Roche)
  • Medecision
  • MCG Health
  • Epic
  • Medical Informatics Corp.
  • Medtronic
  • Oracle Health
  • Philips Healthcare
  • GE Healthcare
  • Stat Pearls

목차

성장 기회 : 조사 범위

  • 분석 범위
  • 용도별 세분화
  • 지역별 세분화
  • 주요 벤더 유형

성장 환경 : CDSS의 전환

  • 왜 성장이 어려워지는가?
  • The Strategic Imperative 8
  • CDSS 업계에 대한 3대 전략적 원칙의 영향

CDSS의 생태계

  • 경쟁 환경
  • 주요 경쟁사

CDSS의 성장 제너레이터

  • CDSS의 진화
  • 주요 이용 사례
  • 주요 시장 동향
  • 주요 과제와 가치 제안
  • 소비자 소리 : CDSS의 AI의 통합
  • CDSS의 잠재적 GenAI 이용 사례
  • AI에 의한 벤더의 가치 제안
  • 규제 시나리오 : CDSS에 대한 FDA 접근법
  • 성장 지표
  • 성장 촉진요인
  • 성장 억제요인
  • 예측에 관한 인사이트
  • 매출 예측
  • 용도별 매출 예측
  • 매출 예측 분석
  • 가격 동향과 예측 분석
  • 지역별 매출 예측
  • CDSS 솔루션 매력도 분석
  • 지역 매력도 순위와 매핑
  • 지역별 매출 예측 분석
  • 매출 점유율 : 경쟁 히트맵
  • 매출 점유율 : 경쟁 히트맵 분석
  • 기업 스포트라이트

성장 제너레이터 : 의사결정 증거/프로토콜

  • 성장 지표
  • 매출 예측
  • 지역별 매출 예측
  • 예측 분석

성장 제너레이터 : 의사결정 애널리틱스

  • 성장 지표
  • 매출 예측
  • 지역별 매출 예측
  • 예측 분석

성장 제너레이터 : 의사결정 워크플로우

  • 성장 지표
  • 매출 예측
  • 지역별 매출 예측
  • 예측 분석

성장 제너레이터 : 의사결정 딜리버리

  • 성장 지표
  • 매출 예측
  • 지역별 매출 예측
  • 예측 분석

성장 기회 유니버스

  • 성장 기회 1 : CDSS의 AI
  • 성장 기회 2 : 중증 환자용 실시간 데이터
  • 성장 기회 3 : 재택 치료용 POC(Point of Care) CDSS

부록과 다음 단계

  • 성장 기회의 이점과 임팩트
  • 다음 단계
  • 첨부 리스트
  • 면책사항
ksm 25.06.16

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support systems (CDSS). These tools facilitate early diagnosis and timely, precise clinical interventions in both hospital and home-based healthcare settings. They also help prevent complications in patient conditions, thereby reducing the need for costly interventions such as hospital readmissions and ICU admissions. Technological advancements in artificial intelligence (AI) and machine learning, including generative AI and conversational AI, are boosting ongoing innovation in CDSS solutions.

This Frost & Sullivan report provides an overview of the global CDSS market, offering a detailed analysis, including a revenue forecast, for each application segment, namely, decision evidence/protocols, decision workflow, decision analytics, and decision delivery. The report also examines the factors driving and restraining this market and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2024, and the forecast period is from 2025 to 2030.

Revenue Forecast

The revenue estimate for the base year 2024 is $10,752.8 million, with a CAGR of 7.6% for the study period from 2024 to 2030.

Scope of Analysis

  • Clinical decision support (CDS) provides clinicians and healthcare staff with knowledge and person-specific information that helps them improve clinical decisions and enhance patient healthcare.
  • A clinical decision support system (CDSS) is a broad concept with many definitions that are used variably. It encompasses a variety of tools to enhance decision-making in the clinical workflow.
  • CDSS includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that consist of the electronic health record (EHR) and are maintained by an IT platform.
  • This report delivers a detailed analysis of the CDSS market and its applications, specifically, decision evidence/protocols, decision workflow, decision analytics, and decision delivery.
  • The report analyzes industry challenges, drivers, and restraints, and offers a revenue forecast for each application area.
  • It covers important business models, the regulatory outlook, cost structures, and the competitive landscape.
  • Description of the top growth opportunities for the global CDSS market in the context of user relevance and calls to action has also been provided.
  • The revenue estimates in this study focus only on revenue attributed to CDSS. In some cases, such as analytics, electronic health records, and device companies, CDSS revenue represents a small part of a larger revenue stream.

The Impact of the Top 3 Strategic Imperatives on the CDSS Industry

Disruptive Technologies

WHY: The CDSS has witnessed significant advancements with the development and integration of new technologies such as AI, cloud, predictive analytics, and mobile platforms, and it will continue to impact CDSS workflows in the next few years. To achieve a highly accessible, flexible, and scalable CDSS solution, end users will continue to look for technology advancements.

FROST PERSPECTIVE: Companies need to identify new use cases and build a strong foundation of evidence-based content. The integration of dynamic AI, specifically, a combination of conversational AI and generative AI (GenAI), can empower end users with easy access to relevant information, enabling them to, for instance, create documents for administrative purposes.

Innovative Business Models

WHY: A high upfront installation and implementation cost has restrained the widespread adoption of CDSS solutions. CDSS has significant potential to improve healthcare outcomes with better clinical recommendations, ultimately benefiting patients and providers in terms of cost and resource utilization.

FROST PERSPECTIVE: Evolving business models such as software-as-a-service (SaaS), subscription models, and risk-based incentives created by technology vendors can provide flexibility in upfront investment and boost CDSS adoption. Growing awareness about the long-term benefits of improved health outcomes and economic growth will drive CDSS growth in the next few years.

Transformative Megatrends

WHY: Medical errors and staff burnout affect healthcare systems' ability to provide optimal patient care. Transitions to home care, a focus on value-based care, an increasing number of data sources, revisions of guidelines, and revenue losses also present significant challenges. Moreover, growing healthcare consumerism and a shift towards personalized care exhaust stakeholders in the face of critical decision-making moments. This is where CDSS has the biggest impact.

FROST PERSPECTIVE: This evolving market demands that vendors regularly update their products and features. Expanding offerings is critical to remaining a viable player. However, such developments cannot happen in isolation. Vendors need to include key end users and decision-makers in their research and development (R&D) programs to best target their investments toward those stakeholders' pain points. To stay ahead of the competition, companies must utilize both organic and inorganic growth pathways.

Key Competitors

  • Optum
  • EBSCO
  • Elsevier
  • Hearst Health
  • Merative
  • Medicomp Systems
  • Wolters Kluwer
  • RethinkFirst
  • Glass Health
  • UNORK
  • Premier Inc. (STANTON HEALTH)
  • Getinge
  • Motive Medical Intelligence
  • athenahealth
  • EvidenceCare
  • HCA Healthcare
  • MEDITECH
  • eClinicalWorks
  • Wolters Kluwer
  • RIMIDI
  • Inovalon
  • Vizio
  • Flatiron Health (Roche)
  • Medecision
  • MCG Health
  • Epic
  • Medical Informatics Corp.
  • Medtronic
  • Oracle Health
  • Philips Healthcare
  • GE Healthcare
  • Stat Pearls

Competitive Environment

Number of Competitors

>50 with revenue greater than $1.0 million

Competitive Factors

Cost, performance, support, technology, reliability, contractor relationships

Key End-user Industry Verticals

Providers, hospitals, primary care centers, medical devices, payers

Leading Competitors

Wolters Kluwer, Philips Healthcare, Optum, Hearst Health, Oracle Health

Revenue Share of Top 4 Competitors (2024)

18.3%

Other Notable Competitors

athenahealth, Elsevier, EBSCO, eClinicalWorks, Epic

Distribution Structure

OEMs, retail sales, direct sales, Cloud-based SaaS

Notable Acquisitions and Mergers

Health Catalyst acquired ARMUS Corporation; Oracle acquired Cerner

Growth Drivers

Value-based Care and Population Health Management: The shift towards value-based care models and population health management strategies has placed a greater emphasis on CDSS. These solutions can assist healthcare providers in identifying high-risk patients, stratifying populations, and developing targeted interventions. By supporting evidence-based decision-making, CDSS contribute to improved patient outcomes and better management of chronic conditions, aligning with the goals of value-based care.

Growing Demand for Personalized Medicine: Personalized medicine, which involves tailoring medical treatment to individual patients based on their unique characteristics, is gaining traction. CDSS can play a crucial role in facilitating personalized medicine by integrating patient-specific data, genetic information, and clinical guidelines to provide tailored recommendations. This growing demand for personalized medicine is a significant driver.

Rising Healthcare Costs and Resource Constraints: Healthcare systems worldwide are facing increasing financial pressures and resource constraints. CDSS can help optimize resource utilization by providing real-time clinical insights, reducing unnecessary tests and procedures, and improving overall efficiency. This cost-effectiveness aspect is a significant driver for the adoption of CDSS solutions.

Growth Restraints

Cost and Budgetary Constraints: Implementing and maintaining CDSS software can be costly, especially for smaller healthcare organizations or those with limited budgets. The investments in hardware, software licenses, infrastructure upgrades, and ongoing maintenance and support costs can be significant. Budgetary constraints may deter healthcare providers from adopting CDSS, especially if they perceive the benefits as uncertain or difficult to quantify.

Clinician Acceptance and Alert Fatigue: Clinicians may be skeptical of automated systems' accuracy or be concerned about a loss of autonomy. Moreover, too many or unimportant alerts may lead to alert fatigue among physicians, affecting the usage of CDSS.

System Integration Complexities: Variations in standards for healthcare records can present challenges in effective CDSS integration with existing hospital IT systems.

Table of Contents

Growth Opportunities: Research Scope

  • Scope of Analysis
  • Segmentation by Application
  • Segmentation by Region
  • Key Vendor Types

Growth Environment: Transformation in CDSS

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the CDSS Industry

Ecosystem in CDSS

  • Competitive Environment
  • Key Competitors

Growth Generators in CDSS

  • Evolution of CDSS
  • Key Use Cases
  • Key Market Trends
  • Key Challenges and Value Proposition
  • Voice of Consumers: AI Integration in CDSS
  • Potential GenAI Use Cases in CDSS
  • Vendor Value Propositions with AI
  • Regulatory Scenario: FDA's Approach to CDSS
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast by Application
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Forecast by Region
  • Analysis of CDSS Solution Attractiveness
  • Regional Attractiveness Ranking and Mapping
  • Revenue Forecast Analysis by Region
  • Revenue Share Competitive Heatmap
  • Revenue Share Competitive Heatmap Analysis
  • Company Spotlight

Growth Generator: Decision Evidence/Protocols

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Analytics

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Workflow

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Delivery

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: AI in CDSS
  • Growth Opportunity 2: Real-time data for Critical Conditions
  • Growth Opportunity 3: Point-of-care CDSS for Home-based Treatment

Appendix and Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제